- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 9, 2024 | 8M sh |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $4.97M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $4.83M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $5.33M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $5.28M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $3.59M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $3.52M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $5.37M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $5.39M |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 8M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $15K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $216K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$4.45M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$4.52M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $800K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $145K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$34K |
| Operating Income | Q1 2024 · Mar 31, 2023 | $2K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $824K |
| Revenue | Q1 2024 · Mar 31, 2023 | $2.09M |